Introducing AQAffinity

Open-source, Structure-free Binding Affinity Prediction Built on OpenFold3

And a global consortium of industry and academic partners

Unlocking the power of OpenFold3 for protein-ligand binding affinity prediction

AQAffinity is an open-source AI model for fast, accurate, structure-free prediction of protein–ligand binding affinities. Built on top of the OpenFold Consortium’s OpenFold3 co-folding model, AQAffinity enables scalable potency prediction without requiring experimentally determined protein structures. AQAffinity expands the functionality of the OpenFold3 model to match the state-of-the-art in structure-aware AI while remaining fully open and accessible.

~1000X faster 

binding affinity prediction compared to physics-based FEP simulation*

* Based on published Boltz2 performance

now available free and open-sourced for everyone!

Affinity Prediction at Screening Scale

Accurate binding affinity prediction is a critical bottleneck in early-stage drug discovery. Experimental screening is expensive and slow, while traditional computational methods such as free energy perturbation (FEP) are too costly to deploy at scale and require highly accurate structural input.

Recent advances in deep-learning–based structure prediction have created a new opportunity: combining predicted structural information with large-scale experimental activity data to enable practical, scalable affinity prediction.

AQAffinity brings this capability to the OpenFold3 ecosystem.

"With AQAffinity, SandboxAQ delivered critical affinity prediction capabilities to OpenFold3 within a few short weeks after the model’s launch, showcasing the company’s technical expertise and commitment to advancing AI-powered open-source tools to accelerate drug discovery.”

- Dr. Woody Sherman, CEO & Founder, Psivant; Executive Member, OpenFold Consortium

Build with AQAffinity

AQAffinity is now available fully open-sourced under the permissive Apache 2.0 license on Hugging Face for academic and industry researchers and developers globally.

We can’t wait to see what you will build using AQAffinity.

Learn more about AQAffinity: 

AQAffinity and OpenFold3 Launch Webinar

with Nvidia and the OpenFold Consortium

February 3, 2026  |  11:00 AM PT / 2:00 PM ET

Learn how OpenFold3, Nvidia and SandboxAQ’s AI simulation technologies are transforming computational drug discovery.

Contact us about AQAffinity


If you’re interested to learn more about AQAffinity, or our other structure-aware AI for drug discovery, we’d love to hear from you. Contact us today to talk to one of our experts.